Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports

Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials

JoAnn E. Manson, Rowan T. Chlebowski, Marcia L. Stefanick et al. · JAMA · 2013 · 1.6K citations · Full text

Medicine, Endocrinology, Gynecology +15

Effects of Continuing or Stopping Alendronate After 5 Years of Treatment

Dennis M. Black, Ann V. Schwartz, Kristine E. Ensrud et al. · JAMA · 2006 · 1.4K citations

Medicine, Pharmacotherapy, Bone Metabolism +16

The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)

Dennis M. Black, Ian R. Reid, Steven Boonen et al. · Journal of Bone and Mineral Research · 2011 · 695 citations · Full text

Medicine, Orthopedic Surgery, Bone Metabolism +10

Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

Henry G. Bone, Michael A. Bolognese, Chui Kin Yuen et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 611 citations

Medicine, Endocrinology, Bone Metabolism +16

Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy

Andrea Z. LaCroix · JAMA · 2011 · 536 citations · Full text

Medicine, Endocrinology, Gynecology +13